Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries has enclosed Press Release titled: ‘Sun Pharma and Zydus sign licensing agreement for co-marketing of Desidustat, a critical treatment for chronic kidney disease patients in India’. This submission is being made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 

The above information is a part of company’s filings submitted to BSE.